Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine Booster

The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002

NCT05928468 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine

NCT04568811 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults

NCT05855408 ·Status: UNKNOWN ·Phase: PHASE4

New Generation mRNA Booster Vaccine Against Emerging VOCs

NCT05580159 ·Status: UNKNOWN ·Phase: PHASE3

A Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19

NCT05394012 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population

NCT04649021 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19

NCT05197153 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years

NCT05345873 ·Status: UNKNOWN ·Phase: PHASE2

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

NCT05960097 ·Status: COMPLETED ·Phase: PHASE2

Exploratory Clinical Study to Evaluation of the Safety and Immunogenicity of Bivalent Vaccine V-01D-351

NCT05583357 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects

NCT04523571 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants

NCT04927065 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster

NCT05609045 ·Status: WITHDRAWN ·Phase: PHASE1

A Real-world Study to Evaluate the Safety and Immunogenicity of a Third-dose Booster After Two Doses of an Inactivated COVID-19 Vaccine

NCT05493917 ·Status: UNKNOWN

Clinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese People

NCT05352867 ·Status: COMPLETED ·Phase: PHASE2

mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs

NCT05686161 ·Status: UNKNOWN ·Phase: PHASE3

Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above

NCT05664932 ·Status: UNKNOWN ·Phase: PHASE3

A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)

NCT04566770 ·Status: COMPLETED ·Phase: PHASE2

Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

NCT05373472 ·Status: COMPLETED ·Phase: PHASE2

Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

NCT05373485 ·Status: COMPLETED ·Phase: PHASE1

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine

NCT05239806 ·Status: UNKNOWN ·Phase: PHASE2

A Phase 1b Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19

NCT05396573 ·Status: UNKNOWN ·Phase: PHASE1

Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector)

NCT04892459 ·Status: COMPLETED ·Phase: PHASE4

A Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants in China

NCT05547243 ·Status: UNKNOWN ·Phase: NA

To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2

NCT05895110 ·Status: COMPLETED ·Phase: NA